Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Etienne Meylan

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Current Biology : CB|November 9, 2004
Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasomeFabio Martinon, Laetitia Agostini, Etienne Meylan, et al.
Oncotarget|September 8, 2018
Snail mediates repression of the Dlk1-Dio3 locus in lung tumor-infiltrating immune cellsSvenja Groeneveld, Julien Faget, Nadine Zangger, et al.
Journal for Immunotherapy of Cancer|July 24, 2021
Neutrophils in the era of immune checkpoint blockadeJulien Faget, Solange Peters, Xavier Quantin, et al.
EMBO Reports|November 26, 2002
RIP4 (DIK/PKK), a novel member of the RIP kinase family, activates NF-kappa B and is processed during apoptosisEtienne Meylan, Fabio Martinon, Margot Thome, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 11, 2017
RANKL Signaling Sustains Primary Tumor Growth in Genetically Engineered Mouse Models of Lung AdenocarcinomaJulien Faget, Caroline Contat, Nadine Zangger, et al.
Cell Death and Differentiation|June 3, 2017
RIP4 inhibits STAT3 signaling to sustain lung adenocarcinoma differentiationJawahar Kopparam, Johanna Chiffelle, Paolo Angelino, et al.
Nature Immunology|April 6, 2004
RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activationEtienne Meylan, Kim Burns, Kay Hofmann, et al.
Nature|September 24, 2005
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virusEtienne Meylan, Joseph Curran, Kay Hofmann, et al.
Journal for Immunotherapy of Cancer|May 17, 2022
Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanomaKatarina Pinjusic, Olivier Andreas Dubey, Olga Egorova, et al.
Nature|October 23, 2009
Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinomaEtienne Meylan, Alison L Dooley, David M Feldser, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Current Biology : CB|November 9, 2004
Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasomeFabio Martinon, Laetitia Agostini, Etienne Meylan, et al.
Oncotarget|September 8, 2018
Snail mediates repression of the Dlk1-Dio3 locus in lung tumor-infiltrating immune cellsSvenja Groeneveld, Julien Faget, Nadine Zangger, et al.
Journal for Immunotherapy of Cancer|July 24, 2021
Neutrophils in the era of immune checkpoint blockadeJulien Faget, Solange Peters, Xavier Quantin, et al.
EMBO Reports|November 26, 2002
RIP4 (DIK/PKK), a novel member of the RIP kinase family, activates NF-kappa B and is processed during apoptosisEtienne Meylan, Fabio Martinon, Margot Thome, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 11, 2017
RANKL Signaling Sustains Primary Tumor Growth in Genetically Engineered Mouse Models of Lung AdenocarcinomaJulien Faget, Caroline Contat, Nadine Zangger, et al.
Cell Death and Differentiation|June 3, 2017
RIP4 inhibits STAT3 signaling to sustain lung adenocarcinoma differentiationJawahar Kopparam, Johanna Chiffelle, Paolo Angelino, et al.
Nature Immunology|April 6, 2004
RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activationEtienne Meylan, Kim Burns, Kay Hofmann, et al.
Nature|September 24, 2005
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virusEtienne Meylan, Joseph Curran, Kay Hofmann, et al.
Journal for Immunotherapy of Cancer|May 17, 2022
Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanomaKatarina Pinjusic, Olivier Andreas Dubey, Olga Egorova, et al.
Nature|October 23, 2009
Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinomaEtienne Meylan, Alison L Dooley, David M Feldser, et al.
Pageof 5